They should have gone for a smaller amount if thats the sort of fail that could happen. And shouldn’t have gone for a large rights issue. I am not familiar with the past of TRT. Gosouth
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025